GlassScriptPhysician profile
Paula M Fishbaugh
NPI 1073504866
$2,983.92
in general payments reported to CMS, 2019-2025
37 companies · $407 in 2025
The $407 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $205 · 2021: $202 · 2022: $943 · 2023: $514 · 2024: $397 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $320.57 | 2019-2025 | Coolseal Generator, Novasure, Acessa Provu System |
| Meditrina | $292.39 | 2022 | |
| Abbvie INC. | $252.36 | 2019-2024 | |
| Medtronic, INC. | $244.74 | 2022-2025 | V-Loc 180, Truclear |
| Aspira Women'S Health INC | $212.12 | 2022-2024 | Ova1 |
| Sage Therapeutics, LLC | $163.24 | 2022-2025 | Zurzuvae |
| Astellas Pharma US INC | $135.19 | 2025 | Veozah |
| Axonics, INC. | $116.23 | 2024 | Bulkamid, Axonics |
| Sumitomo Pharma America, INC. | $103.54 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $98.72 | 2021-2025 | Slynd |
| Organon LLC | $92.04 | 2022-2024 | Nexplanon |
| Coopersurgical, INC. | $88.44 | 2019-2024 | Mara Console |
| Daiichi Sankyo INC. | $80.81 | 2023-2024 | Injectafer |
| Minerva Surgical, INC | $76.36 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $63.47 | 2023-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $60.78 | 2023-2024 | |
| Lupin INC. | $53.80 | 2019-2020 | |
| Myovant Sciences INC. | $49.41 | 2022 | |
| Evofem Biosciences, INC. | $46.77 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $43.65 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.38 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $38.74 | 2019-2021 | |
| Allergan, INC. | $32.95 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $30.39 | 2019 | |
| Therapeuticsmd, INC. | $26.97 | 2020-2021 | |
| Dexcom, INC. | $26.52 | 2025 | Dexcom G6 Transmitter |
| Gynesonics, INC. | $26.09 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ethicon US, LLC | $24.24 | 2019 | |
| Sanofi Pasteur INC. | $18.59 | 2025 | |
| Agile Therapeutics, INC. | $18.53 | 2023 | Twirla |
| Channel Medsystems, INC. | $18.18 | 2025 | |
| Shield Therapeutics INC | $15.90 | 2025 | |
| Amag Pharmaceuticals, INC. | $15.22 | 2019 | |
| Smith+Nephew, INC. | $14.50 | 2020 | |
| Avion Pharmaceuticals | $14.31 | 2020 | |
| Dysis Medical, INC. | $13.28 | 2020 | |
| Medicem INC. | $12.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Fishbaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.